| AbbVie Inc. | Common | $1.2M | 0.5% | 5,037 SH | New |
| Alkermes PLC | Common | $579K | 0.2%Prev: 3.4% | 19,300 SH | Decreased-102,459 SH |
| AllianceBernstein Holding L.P. | Common | $1.8M | 0.7%Prev: 0.9% | 48,000 SH | Increased |
| Alphabet Inc CL A | Common | $73K | 0.0%Prev: 0.1% | 300 SH | Decreased |
| Alphabet Inc-Cl C | Common | $27.3M | 11.0%Prev: 17.1% | 112,220 SH | Decreased+20,800 SH |
| Amazon.com Inc. | Common | $66K | 0.0%Prev: 0.0% | 300 SH | Decreased |
| Apollo Global Management, Inc. | Common | $30.0M | 12.1%Prev: 14.1% | 225,000 SH | Increased |
| Apple Inc. | Common | $635K | 0.3%Prev: 0.4% | 2,494 SH | Decreased |
| Arc Resources Ltd. | Common | $20K | 0.0% | 1,110 SH | New |
| Arcellx Inc | Common | $2.1M | 0.9% | 25,700 SH | New |
| Arcus Biosciences, Inc. | Common | $1.3M | 0.5%Prev: 1.3% | 95,200 SH | Decreased+13,959 SH |
| AtriCure, Inc. | Common | $1.7M | 0.7%Prev: 0.8% | 48,000 SH | Increased-3,400 SH |
| Avadel Pharmaceuticals plc | Common | $5.5M | 2.2% | 363,000 SH | New |
| BioCryst Pharmaceuticals, Inc. | Common | $247K | 0.1% | 32,570 SH | New |
| Biogen Inc. | Common | $280K | 0.1%Prev: 0.5% | 2,000 SH | Decreased-2,000 SH |
| Blackstone Group LP | Common | $36K | 0.0%Prev: 0.0% | 210 SH | Increased |
| Bridgebio Pharma, Inc. | Common | $4.4M | 1.8%Prev: 3.7% | 85,000 SH | Decreased-7,850 SH |
| Brightstar Lottery PLC | Common | $43K | 0.0% | 2,500 SH | New |
| Bristol-Myers Squibb Company | Common | $1.2M | 0.5%Prev: 0.1% | 27,000 SH | Increased+25,000 SH |
| Broadcom, Inc. | Common | $234K | 0.1%Prev: 0.1% | 710 SH | Decreased |
| Calumet, Inc. | Common | $51.6M | 20.8% | 2,825,231 SH | New |
| Canadian Natural Resources Limited | Common | $537K | 0.2%Prev: 0.4% | 16,800 SH | Decreased |
| Catalyst Pharmaceuticals, Inc. | Common | $3.7M | 1.5%Prev: 1.9% | 189,000 SH | Increased+75,000 SH |
| Corteva, Inc. | Common | $747K | 0.3%Prev: 0.1% | 11,051 SH | Increased+9,845 SH |
| CSX Corporation | Common | $2.5M | 1.0% | 70,000 SH | New |
| Cybin Inc | Common | $826K | 0.3%Prev: 1.3% | 140,242 SH | Decreased-229,758 SH |
| Cytokinetics, Incorporated | Common | $1.6M | 0.7% | 30,000 SH | New |
| Danaher Corporation | Common | $36K | 0.0%Prev: 0.0% | 180 SH | Increased |
| Darling Ingredients Inc. | Common | $9.3M | 3.7% | 300,000 SH | New |
| Day One Biopharmaceuticals, Inc. | Common | $920K | 0.4% | 130,500 SH | New |
| DocGo, Inc. | Common | $4.2M | 1.7%Prev: 0.7% | 3,070,850 SH | Increased+400,000 SH |
| Dow Inc. | Common | $28K | 0.0%Prev: 0.0% | 1,206 SH | Decreased |
| DuPont de Nemours, Inc. | Common | $734K | 0.3%Prev: 0.3% | 9,418 SH | Increased+5,651 SH |
| Eastern Bankshares Inc | Common | $91K | 0.0%Prev: 0.1% | 5,000 SH | Decreased |
| Eli Lilly & Co. | Common | $229K | 0.1% | 300 SH | New |
| Fate Therapeutics, Inc. | Common | $460K | 0.2% | 365,000 SH | New |
| FS KKR Capital Corp. | Common | $43K | 0.0%Prev: 0.0% | 2,875 SH | Increased |
| GE HealthCare Technologies Inc | Common | $4K | 0.0%Prev: 0.0% | 50 SH | Increased |
| International Business Machines | Common | $604K | 0.2%Prev: 0.3% | 2,142 SH | Increased |
| Invivyd, Inc. | Common | $110K | 0.0%Prev: 0.0% | 100,000 SH | Increased |
| iShares Biotechnology ETF | Common | $650K | 0.3%Prev: 0.6% | 4,500 SH | Decreased-1,000 SH |
| iShares Russell Mid-Cap Growth | Common | $99K | 0.0%Prev: 0.1% | 695 SH | Decreased |
| Janus Henderson AAA CLO ETF | Common | $22.2M | 9.0%Prev: 2.5% | 437,754 SH | Increased+344,226 SH |
| Jasper Therapeutics, Inc. | Common | $408K | 0.2% | 171,389 SH | New |
| Johnson & Johnson | Common | $1.3M | 0.5%Prev: 0.7% | 6,922 SH | Increased+2,000 SH |
| JPMorgan Chase & Co. | Common | $6.4M | 2.6%Prev: 3.1% | 20,374 SH | Increased+2,276 SH |
| Kimberly-Clark Corporation | Common | $746K | 0.3%Prev: 0.1% | 6,000 SH | Increased+3,600 SH |
| Kura Oncology, Inc. | Common | $596K | 0.2%Prev: 0.3% | 67,302 SH | Increased+14,535 SH |
| Kyndryl Holdings Inc. | Common | $13K | 0.0%Prev: 0.0% | 428 SH | Increased |
| Legacy Housing Corporation | Common | $110K | 0.0%Prev: 0.1% | 4,000 SH | Increased |
| LENZ Therapeutics, Inc. | Common | $3.8M | 1.5% | 82,000 SH | New |
| Liquidia Corporation | Common | $2.5M | 1.0% | 107,783 SH | New |
| Madrigal Pharmaaceuticals, Inc. | Common | $917K | 0.4%Prev: 0.9% | 2,000 SH | Decreased-1,000 SH |
| Mereo BioPharm Group PLC | Common | $619K | 0.2% | 300,337 SH | New |
| Microsoft Corporation | Common | $829K | 0.3%Prev: 0.3% | 1,600 SH | Increased |
| Mondelez International Inc. | Common | $500K | 0.2% | 8,000 SH | New |
| Nvidia Corp | Common | $239K | 0.1%Prev: 0.1% | 1,280 SH | Decreased |
| Occidental Petroleum Corporation | Common | $22K | 0.0%Prev: 0.0% | 469 SH | Decreased |
| Occidential Pertro Wts exp. 8/3/27 | Common | $4K | 0.0%Prev: 0.0% | 194 SH | |
| Orchestra Biomed Holdings, Inc. | Common | $484K | 0.2%Prev: 0.6% | 195,000 SH | Decreased-58,651 SH |
| Pelthos Therapeutics, Inc. | Common | $171K | 0.1%Prev: 0.3% | 6,112 SH | Decreased-15,961 SH |
| Pfizer Inc. | Common | $1.9M | 0.8%Prev: 0.4% | 74,537 SH | Increased+42,200 SH |
| Praxis Precision Medicines, Inc. | Common | $1.5M | 0.6% | 28,000 SH | New |
| Protagonist Therapeutics, Inc | Common | $5.5M | 2.2%Prev: 4.1% | 83,000 SH | Decreased+20,000 SH |
| Quanta Services, Inc. | Common | $73K | 0.0%Prev: 0.1% | 176 SH | Decreased |
| Rezolute, Inc. | Common | $2.6M | 1.0%Prev: 1.0% | 275,000 SH | Increased-95,000 SH |
| Ryman Hospitality Properties, Inc. | Common | $1.1M | 0.4%Prev: 0.2% | 12,000 SH | Increased+9,600 SH |
| Salesforce, Inc. | Common | $18K | 0.0%Prev: 0.0% | 77 SH | Increased |
| Scholar Rock Holding Corporation | Common | $335K | 0.1% | 9,000 SH | New |
| Solid Bioscience Inc. | Common | $1.0M | 0.4%Prev: 0.3% | 162,440 SH | Increased+106,232 SH |
| SPDR S&P Biotech ETF | Common | $501K | 0.2%Prev: 1.3% | 5,000 SH | Decreased-10,000 SH |
| Starwood Property Trust Inc. | Common | $8K | 0.0% | 400 SH | New |
| Syndax Pharmaceutical, Inc. | Common | $6.6M | 2.7%Prev: 5.1% | 428,000 SH | Decreased-9,245 SH |
| Tectonic Therapeutic, Inc. | Common | $1.2M | 0.5% | 74,000 SH | New |
| The Panagram BBB-B CLO | Common | $1.3M | 0.5% | 47,807 SH | New |
| Thermo Fisher Scientific, Inc. | Common | $22K | 0.0%Prev: 0.0% | 45 SH | Decreased |
| Total Energies | Common | $72K | 0.0% | 1,200 SH | New |
| Travere Therapeutics, Inc. | Common | $6.2M | 2.5%Prev: 4.4% | 260,000 SH | Decreased+112,718 SH |
| Ultragenyx Pharmaceutical Inc. | Common | $1.6M | 0.6%Prev: 0.7% | 52,000 SH | Increased+13,931 SH |
| uniQure N.V. | Common | $117K | 0.0% | 2,000 SH | New |
| United Healthcare Corp. | Common | $20K | 0.0%Prev: 0.0% | 57 SH | Decreased |
| United Rental, Inc. | Common | $74K | 0.0%Prev: 0.0% | 78 SH | Decreased |
| Vera Therapeutics, Inc. | Common | $756K | 0.3%Prev: 0.6% | 26,000 SH | Decreased |
| Verona Pharma PLC. | Common | $4.1M | 1.7% | 38,355 SH | New |
| Viridian Therapeutics, Inc. | Common | $2.5M | 1.0%Prev: 1.8% | 116,574 SH | Decreased-64,426 SH |
| Wabtec Corporation | Common | $1K | 0.0%Prev: 0.0% | 6 SH | Decreased |
| Wave Life Science Ltd. | Common | $659K | 0.3%Prev: 0.1% | 90,000 SH | Increased+50,000 SH |
| Xenon Pharmaceuticals Inc. | Common | $440K | 0.2% | 10,962 SH | New |
| Xeris Biopharma Holdings, Inc. | Common | $8.3M | 3.3%Prev: 4.4% | 1,015,000 SH | Decreased-45,000 SH |